These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22877423)

  • 1. Meta-analysis of three randomized trials and nine observational studies comparing drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary artery disease.
    Jang JS; Choi KN; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Urm SH; Chun JH; Kang SJ; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
    Am J Cardiol; 2012 Nov; 110(10):1411-8. PubMed ID: 22877423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of 5,674 patients treated with percutaneous coronary intervention and drug-eluting stents or coronary artery bypass graft surgery for unprotected left main coronary artery stenosis.
    Sá MP; Soares AM; Lustosa PC; Martins WN; Browne F; Ferraz PE; Vasconcelos FP; Lima RC
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):73-80. PubMed ID: 22518037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
    Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of randomized controlled trials on the treatment of unprotected left main coronary artery disease: one-year outcomes with coronary artery bypass grafting versus percutaneous coronary artery intervention with drug-eluting stent.
    Kajimoto K; Miyauchi K; Yamamoto T; Daida H; Amano A
    J Card Surg; 2012 Mar; 27(2):152-7. PubMed ID: 22364383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of effectiveness of first-generation drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary disease.
    Jiang WB; Zhao W; Huang H; Li CL; Zhang JH; Wang Y; Fu GS
    Am J Cardiol; 2012 Dec; 110(12):1764-72. PubMed ID: 23078911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention and drug-eluting stents in patients with unprotected left main coronary artery narrowings.
    Lee MS; Yang T; Dhoot J; Liao H
    Am J Cardiol; 2010 Apr; 105(8):1070-5. PubMed ID: 20381655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry.
    Park DW; Seung KB; Kim YH; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Gwon HC; Jeong MH; Jang YS; Kim HS; Kim PJ; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ
    J Am Coll Cardiol; 2010 Jul; 56(2):117-24. PubMed ID: 20451344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year outcomes following PCI with DES versus CABG for unprotected LM coronary lesions: meta-analysis and meta-regression of 2914 patients.
    Sá MP; Ferraz PE; Escobar RR; Nunes EO; Soares AM; Araújo e Sá FB; Vasconcelos FP; Lima RC
    Rev Bras Cir Cardiovasc; 2013 Mar; 28(1):83-92. PubMed ID: 23739937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Chieffo A; Meliga E; Latib A; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Kim YH; Buszman PE; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2012 Jul; 5(7):718-27. PubMed ID: 22814776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stents versus coronary-artery bypass grafting for left main coronary artery disease.
    Seung KB; Park DW; Kim YH; Lee SW; Lee CW; Hong MK; Park SW; Yun SC; Gwon HC; Jeong MH; Jang Y; Kim HS; Kim PJ; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ
    N Engl J Med; 2008 Apr; 358(17):1781-92. PubMed ID: 18378517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
    Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
    J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials.
    Al Ali J; Franck C; Filion KB; Eisenberg MJ
    JACC Cardiovasc Interv; 2014 May; 7(5):497-506. PubMed ID: 24746647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
    Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW
    Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease.
    Garg A; Rao SV; Agrawal S; Theodoropoulos K; Mennuni M; Sharma A; Garg L; Ferrante G; Meelu OA; Sargsyan D; Reimers B; Cohen M; Kostis JB; Stefanini GG
    Am J Cardiol; 2017 Jun; 119(12):1942-1948. PubMed ID: 28433215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of diabetes mellitus on long-term outcomes of patients with unprotected left main coronary artery disease treated with either drug-eluting stents or coronary artery bypass grafting.
    Yu X; He J; Luo Y; Yuan F; Song X; Gao Y; Li Q; Huang F; Gu C; Lv S; Chen F
    Int Heart J; 2015; 56(1):43-8. PubMed ID: 25742942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis of Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Narrowing.
    Sardar P; Giri J; Elmariah S; Chatterjee S; Kolte D; Kundu A; Nairooz R; Aronow WS; Owan T; Mukherjee D; Feldman DN; Abbott JD
    Am J Cardiol; 2017 Jun; 119(11):1746-1752. PubMed ID: 28400029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of chronic kidney disease on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or drug-eluting stents.
    Pan Y; Qiu Q; Chen F; Li X; Yu X; Luo Y; Li Q; He J; Gao Y; Zhang X; Ren X
    Coron Artery Dis; 2016 Nov; 27(7):535-42. PubMed ID: 27269882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.